Achieve Life Sciences/$ACHV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Achieve Life Sciences
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Ticker
$ACHV
Sector
Primary listing
Employees
28
Headquarters
Website
ACHV Metrics
BasicAdvanced
$256m
-
-$1.25
1.96
-
Price and volume
Market cap
$256m
Beta
1.96
52-week high
$6.03
52-week low
$2.00
Average daily volume
1.5m
Financial strength
Current ratio
4.392
Quick ratio
4.008
Long term debt to equity
52.003
Total debt to equity
69.5
Interest coverage (TTM)
-67.01%
Profitability
EBITDA (TTM)
-54.652
Management effectiveness
Return on assets (TTM)
-85.30%
Return on equity (TTM)
-257.67%
Valuation
Price to book
11.87
Price to tangible book (TTM)
12.95
Price to free cash flow (TTM)
-4.23
Free cash flow yield (TTM)
-23.64%
Free cash flow per share (TTM)
-1.135
Growth
Earnings per share change (TTM)
0.94%
3-year earnings per share growth (CAGR)
-32.06%
What the Analysts think about ACHV
Analyst ratings (Buy, Hold, Sell) for Achieve Life Sciences stock.
ACHV Financial Performance
Revenues and expenses
ACHV Earnings Performance
Company profitability
ACHV News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Achieve Life Sciences stock?
Achieve Life Sciences (ACHV) has a market cap of $256M as of May 08, 2026.
What is the P/E ratio for Achieve Life Sciences stock?
The price to earnings (P/E) ratio for Achieve Life Sciences (ACHV) stock is 0 as of May 08, 2026.
Does Achieve Life Sciences stock pay dividends?
No, Achieve Life Sciences (ACHV) stock does not pay dividends to its shareholders as of May 08, 2026.
When is the next Achieve Life Sciences dividend payment date?
Achieve Life Sciences (ACHV) stock does not pay dividends to its shareholders.
What is the beta indicator for Achieve Life Sciences?
Achieve Life Sciences (ACHV) has a beta rating of 1.96. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.